Multiple Approaches to Support Young Breast Cancer Survivors and Metastatic Breast Cancer Patients

 

Goals resulting from providing support to young breast cancer survivors and metastatic breast cancer patients include: increased support for caregivers and families for these individuals, increased awareness of clinical trials by both young women diagnosed with cancer and individuals diagnosed with metastic breast cancer, increased financial support, and improved quality of life among young breast cancer survivors.

Deleted 03/27/2024 (Archived.) 93.373 Centers For Disease Control and Prevention, Department of Health and Human Services A - Formula Grants; B - Project Grants Fiscal Year 2018 Seven funded programs implemented evidenced-based interventions that focus on: 1) assistance in coping with the effects of treatment (e.g., psychosocial health, reproductive health, financial concerns); and/or 2) provision of information about follow-up care, risk of recurrence and new malignancies, fertility, psychosocial support, risk of family members developing breast cancer, genetic testing, and general health promotion (including quality of life). Statute ,
This statute amends the US Public Health Service Act, which allows for the provision of: (1) campaigns to educate the public and health care professionals about young women's breast health, (2) research that explores strategies to prevent breast cancer in young women, and (3) support for young women with breast cancer. Government organizations, non-governmental organizations, private colleges and universities, community-based organizations, faith-based organizations, for-profit organizations (other than small business), and small businesses can apply. Not applicable. Not applicable. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. Review and Selection Process: Applications will be reviewed in three phases. Phase I Review: applications will be reviewed initially for completeness by CDC OGS staff and will be reviewed jointly for eligibility by the CDC NCCDPHP DCPC and OGS. Phase II Review: A review panel will evaluate complete, eligible applications in accordance with the "Criteria" section of the NOFO. Phase III Review: Applications will be funded in order by score and rank determined by the review panel. May 1, 2019 to July 1, 2019 Application Deadline: TBD, 11:59 p.m. U.S. Eastern Standard Time, on www.grants.gov *** dates are approximate or TBD until draft NOFO is finalized and ready for publishing. Letters of Intent due - ~June 3, 2019 From 60 to 90 days. N/A Not applicable. From 60 to 90 days. Upon availability of funds and/or successful performance, CDC/OFR will provide instructions on renewal and/or continuation during each budget year of the project. I. Approach II. Evaluation and Performance Measurement III. Applicant's Organizational Capacity to Implement the Approach Due Date for Applications: TBD, 11:59 p.m. U.S. Eastern Standard Time, at www.grants.gov. Performance Reports: Awardee Evaluation and Performance Measurement Plan: Risk questionnaire Not applicable. Statutory Formula: Title N/A

Matching is . Cost share and/or matching requirements: N/A

MOE requirements are not applicable to this assistance listing. 9/30/2019 – 9/29/2024 Centers for Disease Prevention and Control (CDC) Division of Cancer Prevention and Control (DCPC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) Angela R. Moore, MPH
4770 Buford Highway
Chamblee Campus, Building 107/4th Floor
Atlanta, GA 30341 USA
ARMoore@cdc.gov
Phone: 770.488.3094 75-0943-0-1-551 (Formula Grants (Cooperative Agreements)) FY 18$800,000.00; FY 19 est $0.00; FY 20 est $0.00; FY 17$180,000.00; - (Cooperative Agreements) FY 18$800,000.00; FY 19 est $0.00; FY 20 est $0.00; - DP11-1111: $180,000 (Average award) DP14-1408: Component 1 ($200,000 - $450,000); Component 2 ($150,000 to $350,000) DP19-1906: TBD Not applicable. Fiscal Year 2017 FOA DP11-1111: ~$5,346,075 3 Year Project: 9/30/11 - 9/29/14
Fiscal Year 2018 CDC-RFA-DP14-1408: ~$11,995,825 5 Year Project: 9/30/2014 – 9/29/2019
Fiscal Year 2019 CDC-RFA-DP19-1906: ~$1,800,000 5 Year Project: 9/30/2019 – 9/9/29/2024